"Surface-Active Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.
Descriptor ID |
D013501
|
MeSH Number(s) |
D27.720.877
|
Concept/Terms |
Surface-Active Agents- Surface-Active Agents
- Agents, Surface-Active
- Surface Active Agents
- Active Agents, Surface
- Agents, Surface Active
|
Below are MeSH descriptors whose meaning is more general than "Surface-Active Agents".
Below are MeSH descriptors whose meaning is more specific than "Surface-Active Agents".
This graph shows the total number of publications written about "Surface-Active Agents" by people in this website by year, and whether "Surface-Active Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Surface-Active Agents" by people in Profiles.
-
Biocompatibility and characterization of a peptide amphiphile hydrogel for applications in peripheral nerve regeneration. Tissue Eng Part A. 2015 Apr; 21(7-8):1333-42.
-
Protective effect of P188 in the model of acute trauma to human ankle cartilage: the mechanism of action. J Orthop Trauma. 2010 Sep; 24(9):571-6.
-
Immuno-targeting of nonionic surfactant vesicles to inflammation. Int J Pharm. 2007 Jul 18; 339(1-2):222-30.
-
Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol. 1999 Jun 15; 83(12):1600-5.
-
Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function. Int J Cancer. 1996 Oct 09; 68(2):245-50.
-
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996 Oct 01; 78(7):747-50.
-
Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int J Cancer. 1996 Jan 03; 65(1):74-9.
-
Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents. Int J Cancer. 1995 Aug 09; 62(4):436-42.
-
Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch Biochem Biophys. 1995 May 10; 319(1):309-15.
-
Isolation and characterization of a regulatory gene affecting rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. J Bacteriol. 1994 Apr; 176(7):2044-54.